Saturday, June 27, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 787 of 1,261
  1. US 8859506

    Glycopeptide phosphonate derivatives

    THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted
  2. US 8858925

    Pegylated fibrinogen precursor molecule

    REGENTIS BIOMATERIALS LTD. · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted
  3. US 8859498

    Targeted therapeutic proteins

    BIOMARIN PHARMACEUTICAL INC. · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted
  4. US 8859520

    Methods for therapy of neurodegenerative disease of the brain

    The Regents of the University of California · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted
  5. US 8859527

    Inclusion complex of deoxypodophyllotoxin of cyclodextrin, preparation method, use for treatment of cancer thereof

    CHINA PHARMACEUTICAL UNIVERSITY · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted
  6. US 8859619

    Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy

    Jazz Pharmaceuticals, Inc. · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted
  7. US 8858959

    Gel vaccine delivery system for treating poultry

    The United States of America, as represented by the Secretary of Agriculture · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted
  8. US 8859207

    Pharmaceutical compositions which inhibit FKBP52-mediated regulation of androgen receptor function and methods of using same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted
  9. US 8859284

    Delivery of nanoparticles to neurons

    United States of America as represented by the Secretary of the Air Force · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted
  10. US 8858930

    Live attenuated bacterial vaccine to reduce or inhibit carriage and shedding of enterohemorrhagic Escherichia coli in cattle

    The United States of America as represented by the Department of Veteran Affairs · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted
  11. US 8858945

    Three-dimensional structure of complement receptor type 2 and uses thereof

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted
  12. US 8859516

    Lipid formulated compositions and methods for inhibiting expression of Eg5 and VEGF genes

    Alnylam Pharmaceuticals, Inc. · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted
  13. US 8858978

    Heat cured gel and method of making

    ATRIUM MEDICAL CORPORATION · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted
  14. US 8858946

    Method for inhibiting HIV-1 replication utilizing anti-GBV-C E2 antibodies

    THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF VETERANS AFFAIRS · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted
  15. US 8858950

    Delivery of pharmaceutical agents via the human insulin receptor

    The Regents of the University of California · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted
  16. US 8859736

    Monoclonal antibodies that inhibit the wnt signaling pathway and methods of production and use thereof

    The Board of Regents of the University of Oklahoma · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted
  17. US 8858938

    Human monoclonal antibodies against Hendra and Nipah viruses

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted
  18. US 8859774

    Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators

    Corcept Therapeutics Incorporated · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted
  19. US 8859727

    Bioactive FUS1 peptides and nanoparticle-polypeptide complexes

    The Board of Regents of the University of Texas System · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted
  20. US 8859750

    RNAi modulation of RSV and therapeutic uses thereof

    Alnylam Pharmaceuticals, Inc. · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted
  21. WO 2014163518

    TRAITEMENTS UTILISANT L'ESLICARBAZÉPINE ET L'ACÉTATE D'ESLICARBAZÉPINE

    BIAL PORTELA & Cª S A [PT] · Granted Oct 9, 2014 · Expires Oct 4, 2034

    granted
  22. CA 2908706

    TRAITEMENTS UTILISANT L'ESLICARBAZEPINE ET L'ACETATE D'ESLICARBAZEPINE

    BIAL PORTELA & CA SA [PT] · Granted Oct 9, 2014 · Expires Oct 4, 2034

    granted
  23. CA 2905273

    RENFORCATEURS D'HYDROSOLUBILITE A BASE DE GLYCOGENE

    ACRAF [IT] · Granted Oct 9, 2014 · Expires Oct 4, 2034

    granted
  24. US 8853427

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.